Insiders · PYXS

PYXS insider transactions

Pyxis Oncology Inc. (PYXS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PYXS

• 31d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Flavin John L

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Lewis-Hall Freda C

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Cline Darren S

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 31d
  SEC Form 4 filed by Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 79d
  SEC Form 4 filed by Interim CEO Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by President ,CEO & CMO Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by SVP, Chief Accounting Officer Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Humphrey Rachel

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Lewis-Hall Freda C

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Cline Darren S

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by CFO & COO Connealy Pamela Ann

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 389d
  SEC Form 4 filed by Director Flavin John L

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 488d
  SEC Form 4 filed by Chief Executive Officer Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 488d
  SEC Form 4 filed by CFO & COO Connealy Pamela Ann

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 488d
  SEC Form 4 filed by SVP, Chief Accounting Officer Wadhane Jitendra

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 514d
  CFO & COO Connealy Pamela Ann bought $174,364 worth of shares (88,850 units at $1.96) (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 684d
  SEC Form 4 filed by Director Metzger Michael A

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 684d
  SEC Form 3 filed by new insider Metzger Michael A

  3 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 687d
  Palani Santhosh was granted 6,000 shares (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Flavin John L was granted 35,219 shares, increasing direct ownership by 9% to 413,015 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  SEC Form 4 filed by Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Humphrey Rachel was granted 38,741 shares, increasing direct ownership by 67% to 96,805 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Cline Darren S was granted 35,219 shares, increasing direct ownership by 16% to 251,405 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Connealy Pamela Ann was granted 328,710 shares, increasing direct ownership by 42% to 1,110,293 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Dupont Jakob was granted 38,741 shares (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Lewis-Hall Freda C was granted 35,219 shares, increasing direct ownership by 17% to 241,405 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  SEC Form 4 filed by Civik Thomas

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 758d
  Wadhane Jitendra was granted 131,484 shares, increasing direct ownership by 49% to 398,421 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 773d
  SEC Form 4 filed by Palani Santhosh

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 773d
  SEC Form 3 filed by new insider Palani Santhosh

  3 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 848d
  SEC Form 4 filed by Kobayashi Ken

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 871d
  SEC Form 3 filed by new insider Kobayashi Ken

  3 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 877d
  Connealy Pamela Ann covered exercise/tax liability with 36,949 shares, decreasing direct ownership by 5% to 781,583 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 890d
  Wadhane Jitendra was granted 40,000 shares, increasing direct ownership by 18% to 266,937 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 940d
  Connealy Pamela Ann bought $14,960 worth of shares (8,000 units at $1.87), increasing direct ownership by 0.99% to 818,532 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 941d
  Wadhane Jitendra bought $4,675 worth of shares (2,500 units at $1.87), increasing direct ownership by 1% to 226,937 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 941d
  Connealy Pamela Ann bought $11,868 worth of shares (6,426 units at $1.85), increasing direct ownership by 0.80% to 810,532 units (SEC Form 4)

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 942d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 943d
  SEC Form 4: Wadhane Jitendra bought $8,850 worth of shares (5,000 units at $1.77), increasing direct ownership by 2% to 224,437 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 943d
  SEC Form 4: Connealy Pamela Ann bought $20,044 worth of shares (12,000 units at $1.67), increasing direct ownership by 2% to 804,106 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 946d
  SEC Form 4: Wadhane Jitendra bought $4,349 worth of shares (2,500 units at $1.74), increasing direct ownership by 1% to 219,437 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 946d
  SEC Form 4: Connealy Pamela Ann bought $8,695 worth of shares (5,000 units at $1.74), increasing direct ownership by 0.64% to 792,106 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 950d
  SEC Form 4: Sullivan Lara sold $18,161 worth of shares (8,641 units at $2.10), decreasing direct ownership by 0.36% to 2,403,882 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 955d
  SEC Form 4: Sullivan Lara sold $63,301 worth of shares (27,917 units at $2.27) and covered exercise/tax liability with 184,742 shares, decreasing direct ownership by 8% to 2,412,523 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 960d
  SEC Form 4: Connealy Pamela Ann was granted 187,793 shares, increasing direct ownership by 32% to 782,106 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 960d
  SEC Form 4: Wadhane Jitendra was granted 93,896 shares, increasing direct ownership by 80% to 211,937 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 960d
  SEC Form 4: Sullivan Lara was granted 469,483 shares, increasing direct ownership by 22% to 2,625,182 units

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 974d
  SEC Form 4 filed by Dupont Jakob

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 974d
  SEC Form 3 filed by new insider Dupont Jakob

  3 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1124d
  SEC Form 4 filed by Sullivan Lara

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)
• 1124d
  SEC Form 4 filed by Yanchik Connealy Pamela

  4 - Pyxis Oncology, Inc. (0001782223) (Issuer)